Comprehensive overview of consumer (patient) posts from June 2014-June 2016 from key websites.

Posts cover the following treatments:
•Harvoni (591 posts)
•Olysio (360 posts)
•Sovaldi (172 posts)
•Viekira Pak (93 posts)
•Daklinza (15 posts)
•Zepatier (5 posts)
•Technivie (2 posts)
•Pegasys/IFN/other (15 posts)

TOTAL: 1,253 posts

•Next wave will also include Epclusa

Report explains the following:

•Sentiment toward individual treatments
•Patient characteristics associated with each treatment
•Clinical outcomes, side effects, and comparisons for each treatment
•Treatment dynamics associated with obtaining and taking HCV therapies
•Treatment dynamics changes from June 2014 to June 2016
•In total, over 200 slides of results